Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT).

Authors

null

Doris M. Ponce

Memorial Sloan Kettering Cancer Center, New York, NY

Doris M. Ponce , Swarna Pandian , Marcel R. M. van den Brink , Satyajit Kosuri , Nandita Khera , Zachariah Michael DeFilipp , Bindu Tejura , David I Lichter , Meghan Chafee , Kankana Bardhan , Nathan D Hicks , Emily Walsh , Mary-Jane Lombardo , Christopher B. Ford , Lisa von Moltke , Matthew R. Henn , Jonathan U. Peled

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Allogenic Stem Cell Transplantation

Clinical Trial Registration Number

NCT04995653

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 6554)

DOI

10.1200/JCO.2024.42.16_suppl.6554

Abstract #

6554

Poster Bd #

113

Abstract Disclosures

Similar Posters

Poster

2013 Gastrointestinal Cancers Symposium

Microenvironment and cytokines in pseudomyxoma peritonei.

Microenvironment and cytokines in pseudomyxoma peritonei.

First Author: Kush Lohani

First Author: Lucia Masarova

First Author: Po-Ju Lin

First Author: Charles Stewart Kamen